blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2076246

EP2076246 - FORMATION OF MEDICALLY USEFUL GELS COMPRISING MICROPOROUS PARTICLES AND METHODS OF USE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  05.01.2018
Database last updated on 22.08.2024
FormerThe patent has been granted
Status updated on  27.01.2017
FormerGrant of patent is intended
Status updated on  20.01.2017
Most recent event   Tooltip06.03.2020Lapse of the patent in a contracting state
New state(s): TR		published on 08.04.2020  [2020/15]
Applicant(s)For all designated states
MEDAFOR, INCORPORATED
2700 Freeway bld Suite 800
Minneapolis MN 55430 / US
[2009/28]
Inventor(s)01 / DRAKE, James F.
901 - 20th Avenue SE
Minneapolis MN 55414 / US
02 / GRONDA, Ann
1314 Kari Lane
New Brighton MN 55112 / US
 [2009/28]
Representative(s)Ipside
6, Impasse Michel Labrousse
31100 Toulouse / FR
[2017/09]
Former [2009/28]Schmit, Christian Norbert Marie
SCHMIT CHRETIEN 8, place du Ponceau
95000 Cergy / FR
Application number, filing date07852671.211.10.2007
[2009/28]
WO2007US21732
Priority number, dateUS2006058037213.10.2006         Original published format: US 580372
[2009/28]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2008048468
Date:24.04.2008
Language:EN
[2008/17]
Type: A1 Application with search report 
No.:EP2076246
Date:08.07.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 24.04.2008 takes the place of the publication of the European patent application.
[2009/28]
Type: B1 Patent specification 
No.:EP2076246
Date:01.03.2017
Language:EN
[2017/09]
Search report(s)International search report - published on:US24.04.2008
(Supplementary) European search report - dispatched on:EP24.09.2012
ClassificationIPC:A61K9/14, A61K9/00, A61K9/10, A61K9/70, A61L26/00
[2012/43]
CPC:
A61L26/008 (EP,US); A61K9/06 (KR); A61K38/48 (KR);
A61K9/10 (EP,US); A61K9/14 (EP,US); A61K9/16 (KR);
A61K9/7015 (EP,US); A61L26/0052 (EP,US); A61P17/00 (EP);
A61P41/00 (EP) (-)
Former IPC [2009/28]A61K9/14, A61K9/00
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2017/09]
Former [2009/28]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesALNot yet paid
BANot yet paid
HRNot yet paid
MKNot yet paid
RSNot yet paid
TitleGerman:FORMIERUNG MEDIZINISCH NÜTZLICHER GELE MIT MIKROPORÖSEN PARTIKELN UND VERWENDUNGSVERFAHREN DAFÜR[2009/28]
English:FORMATION OF MEDICALLY USEFUL GELS COMPRISING MICROPOROUS PARTICLES AND METHODS OF USE[2009/28]
French:FORMATION DE GELS MÉDICALEMENT UTILES COMPRENANT DES PARTICULES MICROPOREUSES ET LEURS PROCÉDÉS D'UTILISATION[2009/28]
Entry into regional phase12.05.2009National basic fee paid 
12.05.2009Search fee paid 
12.05.2009Designation fee(s) paid 
12.05.2009Examination fee paid 
Examination procedure12.05.2009Examination requested  [2009/28]
10.04.2013Amendment by applicant (claims and/or description)
16.10.2013Despatch of a communication from the examining division (Time limit: M04)
03.02.2014Reply to a communication from the examining division
01.03.2016Despatch of a communication from the examining division (Time limit: M06)
22.07.2016Reply to a communication from the examining division
07.10.2016Communication of intention to grant the patent
19.01.2017Fee for grant paid
19.01.2017Fee for publishing/printing paid
19.01.2017Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  16.10.2013
Opposition(s)04.12.2017No opposition filed within time limit [2018/06]
Fees paidRenewal fee
26.10.2009Renewal fee patent year 03
27.12.2010Renewal fee patent year 04
25.10.2011Renewal fee patent year 05
25.10.2012Renewal fee patent year 06
28.10.2013Renewal fee patent year 07
27.10.2014Renewal fee patent year 08
12.10.2015Renewal fee patent year 09
11.10.2016Renewal fee patent year 10
Penalty fee
Additional fee for renewal fee
31.10.201004   M06   Fee paid on   27.12.2010
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU11.10.2007
AT01.03.2017
CY01.03.2017
CZ01.03.2017
DK01.03.2017
EE01.03.2017
FI01.03.2017
LT01.03.2017
LV01.03.2017
MC01.03.2017
NL01.03.2017
PL01.03.2017
RO01.03.2017
SE01.03.2017
SI01.03.2017
SK01.03.2017
TR01.03.2017
BG01.06.2017
GR02.06.2017
IS01.07.2017
PT03.07.2017
IE11.10.2017
LU11.10.2017
MT11.10.2017
BE31.10.2017
CH31.10.2017
LI31.10.2017
[2020/15]
Former [2019/46]HU11.10.2007
AT01.03.2017
CY01.03.2017
CZ01.03.2017
DK01.03.2017
EE01.03.2017
FI01.03.2017
LT01.03.2017
LV01.03.2017
MC01.03.2017
NL01.03.2017
PL01.03.2017
RO01.03.2017
SE01.03.2017
SI01.03.2017
SK01.03.2017
BG01.06.2017
GR02.06.2017
IS01.07.2017
PT03.07.2017
IE11.10.2017
LU11.10.2017
MT11.10.2017
BE31.10.2017
CH31.10.2017
LI31.10.2017
Former [2019/31]HU11.10.2007
AT01.03.2017
CZ01.03.2017
DK01.03.2017
EE01.03.2017
FI01.03.2017
LT01.03.2017
LV01.03.2017
MC01.03.2017
NL01.03.2017
PL01.03.2017
RO01.03.2017
SE01.03.2017
SI01.03.2017
SK01.03.2017
BG01.06.2017
GR02.06.2017
IS01.07.2017
PT03.07.2017
IE11.10.2017
LU11.10.2017
MT11.10.2017
BE31.10.2017
CH31.10.2017
LI31.10.2017
Former [2018/45]AT01.03.2017
CZ01.03.2017
DK01.03.2017
EE01.03.2017
FI01.03.2017
LT01.03.2017
LV01.03.2017
MC01.03.2017
NL01.03.2017
PL01.03.2017
RO01.03.2017
SE01.03.2017
SI01.03.2017
SK01.03.2017
BG01.06.2017
GR02.06.2017
IS01.07.2017
PT03.07.2017
IE11.10.2017
LU11.10.2017
MT11.10.2017
BE31.10.2017
CH31.10.2017
LI31.10.2017
Former [2018/43]AT01.03.2017
CZ01.03.2017
DK01.03.2017
EE01.03.2017
FI01.03.2017
LT01.03.2017
LV01.03.2017
MC01.03.2017
NL01.03.2017
PL01.03.2017
RO01.03.2017
SE01.03.2017
SI01.03.2017
SK01.03.2017
BG01.06.2017
GR02.06.2017
IS01.07.2017
PT03.07.2017
LU11.10.2017
MT11.10.2017
BE31.10.2017
CH31.10.2017
LI31.10.2017
Former [2018/36]AT01.03.2017
CZ01.03.2017
DK01.03.2017
EE01.03.2017
FI01.03.2017
LT01.03.2017
LV01.03.2017
MC01.03.2017
NL01.03.2017
PL01.03.2017
RO01.03.2017
SE01.03.2017
SI01.03.2017
SK01.03.2017
BG01.06.2017
GR02.06.2017
IS01.07.2017
PT03.07.2017
LU11.10.2017
BE31.10.2017
CH31.10.2017
LI31.10.2017
Former [2018/35]AT01.03.2017
CZ01.03.2017
DK01.03.2017
EE01.03.2017
FI01.03.2017
LT01.03.2017
LV01.03.2017
MC01.03.2017
NL01.03.2017
PL01.03.2017
RO01.03.2017
SE01.03.2017
SI01.03.2017
SK01.03.2017
BG01.06.2017
GR02.06.2017
IS01.07.2017
PT03.07.2017
LU11.10.2017
CH31.10.2017
LI31.10.2017
Former [2018/29]AT01.03.2017
CZ01.03.2017
DK01.03.2017
EE01.03.2017
FI01.03.2017
LT01.03.2017
LV01.03.2017
MC01.03.2017
NL01.03.2017
PL01.03.2017
RO01.03.2017
SE01.03.2017
SI01.03.2017
SK01.03.2017
BG01.06.2017
GR02.06.2017
IS01.07.2017
PT03.07.2017
Former [2018/14]AT01.03.2017
CZ01.03.2017
DK01.03.2017
EE01.03.2017
FI01.03.2017
LT01.03.2017
LV01.03.2017
NL01.03.2017
PL01.03.2017
RO01.03.2017
SE01.03.2017
SI01.03.2017
SK01.03.2017
BG01.06.2017
GR02.06.2017
IS01.07.2017
PT03.07.2017
Former [2018/09]AT01.03.2017
CZ01.03.2017
DK01.03.2017
EE01.03.2017
FI01.03.2017
LT01.03.2017
LV01.03.2017
NL01.03.2017
PL01.03.2017
RO01.03.2017
SE01.03.2017
SK01.03.2017
BG01.06.2017
GR02.06.2017
IS01.07.2017
PT03.07.2017
Former [2017/51]AT01.03.2017
CZ01.03.2017
EE01.03.2017
FI01.03.2017
LT01.03.2017
LV01.03.2017
NL01.03.2017
PL01.03.2017
RO01.03.2017
SE01.03.2017
SK01.03.2017
BG01.06.2017
GR02.06.2017
IS01.07.2017
PT03.07.2017
Former [2017/50]AT01.03.2017
CZ01.03.2017
EE01.03.2017
FI01.03.2017
LT01.03.2017
LV01.03.2017
NL01.03.2017
PL01.03.2017
RO01.03.2017
SE01.03.2017
SK01.03.2017
BG01.06.2017
GR02.06.2017
IS01.07.2017
Former [2017/49]AT01.03.2017
CZ01.03.2017
EE01.03.2017
FI01.03.2017
LT01.03.2017
LV01.03.2017
NL01.03.2017
RO01.03.2017
SE01.03.2017
SK01.03.2017
BG01.06.2017
GR02.06.2017
IS01.07.2017
Former [2017/48]AT01.03.2017
CZ01.03.2017
FI01.03.2017
LT01.03.2017
LV01.03.2017
NL01.03.2017
SE01.03.2017
BG01.06.2017
GR02.06.2017
Former [2017/41]AT01.03.2017
FI01.03.2017
LT01.03.2017
LV01.03.2017
NL01.03.2017
SE01.03.2017
BG01.06.2017
GR02.06.2017
Documents cited:Search[XI]US6060461  (DRAKE JAMES FRANKLIN [US]) [X] 1-10,15-20 * column 3, line 41 - line 47 * * column 4, line 5 - line 54 * * column 6, line 30 - line 41 * * column 7, line 1 - line 12 *[I] 11-14;
 [XI]WO0164148  (HEMARREST INC [US]) [X] 1-10,15-20 * page 4, lines 3, 4 * * page 5, lines 19, 20 * * page 6, lines 1, 2, 20-25 * * page 9, line 10 - line 13 * * page 9, line 31 - line 33 * * page 10, line 1 - line 7 * [I] 11-14;
 [X]US2001047187  (MILO CHARLES F [US], et al) [X] 1-16,19,20 * page 6, paragraphs 94, 96 * * page 9, paragraph 145 * * page 10, paragraph 158 * * page 11, paragraph 175 *;
 [X]US2003108511  (SAWHNEY AMARPREET S [US]) [X] 1-16,19,20 * page 1, paragraphs 7, 8, 11 * * page 3, paragraph 42 * * page 18, paragraph 184 * * page 19, paragraph 190 * * example 10 *
International search[Y]US6060461  (DRAKE JAMES FRANKLIN [US]);
 [Y]US2003108511  (SAWHNEY AMARPREET S [US])
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.